Clearance Summary
NEW JERSEY FEMORAL RESURFACING COMPONENT received FDA 510(k) clearance under submission number K842233, sponsored by Endomedics, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 1984-07-20.
- Submission: K842233
- Applicant / Sponsor: Endomedics, Inc.
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3400
- Decision date: 1984-07-20
Classification & Regulation
This clearance is catalogued under FDA product code KXA and 21 CFR 888.3400, within the Orthopedic review panel as a Class II device.